CD20+ B-cell infiltration is related to the time after transplant and poor prognosis of acute cellular rejection in renal transplant

Experimental and Clinical Transplantation

Volumn 11, Issue 5, 2013, Pages 412-417

  Jiqiu, Wen ^a   Jinsong, Chen ^a   Dongrui, Cheng ^a   Chao, Zhang Ming ^a   Shuming, Ji ^a   Zhi Hong, Liu ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Acute cellular rejection; CD20; Graft survival; Renal transplant; Time course

Indexed keywords

CD20 ANTIGEN; CD4 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; HYALIN;

ACUTE GRAFT REJECTION; ADULT; ANTIGEN EXPRESSION; ARTERIOLE; ARTICLE; B LYMPHOCYTE; CELL DENSITY; CELL EXPANSION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; KIDNEY ALLOGRAFT; KIDNEY HYPERTROPHY; KIDNEY TUBULE; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PROGNOSIS; RISK FACTOR;

ACUTE DISEASE; ADULT; ANTIGENS, CD20; B-LYMPHOCYTES; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; FEMALE; GRAFT REJECTION; HLA-DR ANTIGENS; HUMANS; HYALIN; IMMUNITY, CELLULAR; KAPLAN-MEIER ESTIMATE; KIDNEY; KIDNEY TRANSPLANTATION; LEAST-SQUARES ANALYSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84885624069     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: 10.6002/ect.2012.0143     Document Type: Article

References (20)

1. Sarwal M, Chua MS, Kambham N, et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med. 2003;349(2):125-138.
2. Hippen BE, DeMattos A, Cook WJ, Kew CE 2nd, Gaston RS. Association of CD20+ infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts. Am J Transplant. 2005;5(9):2248-2252.
3. Tsai EW, Rianthavorn P, Gjertson DW, Wallace WD, Reed EF, Ettenger RB. CD20+ lymphocytes in renal allografts are associated with poor graft survival in pediatric patients. Transplantation. 2006;82(12):1769-1773.
4. Kayler LK, Lakkis FG, Morgan C, et al. Acute cellular rejection with CD20-positive lymphoid clusters in kidney transplant patients following lymphocyte depletion. Am J Transplant. 2007;7(4):949-954.
5. Hwang HS, Song JH, Hyoung BJ, et al. Clinical impacts of CD38+ B cells on acute cellular rejection with CD20+ B cells in renal allograft. Transplantation. 2010;89(12):1489-1495.
6. Lehnhardt A, Mengel M, Pape L, Ehrich JH, Offner G, Strehlau J. Nodular B-cell aggregates associated with treatment refractory renal transplant rejection resolved by rituximab. Am J Transplant. 2006;6(4):847-851.
7. Pescovitz MD. The use of rituximab, anti-CD20 monoclonal antibody, in pediatric transplantation. Pediatr Transplant. 2004;8(1):9-21.
8. Scheepstra C, Bemelman FJ, van der Loos C, et al. B cells in cluster or in a scattered pattern do not correlate with clinical outcome of renal allograft rejection. Transplantation. 2008;86(6):772-778.
9. Bagnasco SM, Tsai W, Rahman MH, et al. CD20-positive infiltrates in renal allograft biopsies with acute cellular rejection are not associated with worse graft survival. Am J Transplant. 2007;7(8):1968-1973.
10. Doria C, di Francesco F, Ramirez CB, et al. The presence of B-cell nodules does not necessarily portend a less favorable outcome to therapy in patients with acute cellular rejection of a renal allograft. Transplant Proc. 2006;38(10):3441-3444.
11. Rivera A, Chen CC, Ron N, Dougherty JP, Ron Y. Role of B cells as antigen-presenting cells in vivo revisited: antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations. Int Immunol. 2001;13(12):1583-1593.
12. Zarkhin V, Kambham N, Li L, et al. Characterization of intra-graft B cells during renal allograft rejection. Kidney Int. 2008;74(5):664-673.
13. Girlanda R, Kleiner DE, Duan Z, et al. Monocyte infiltration and kidney allograft dysfunction during acute rejection. Am J Transplant. 2008;8(3):600-607.
14. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int. 1999;55(2):713-723.
15. Sun Q, Liu ZH, Ji S, et al. Late and early C4d-positive acute rejection: different clinico-histopathological subentities in renal transplantation. Kidney Int. 2006;70(2):377-383.
16. Massy ZA, Guijarro C, Wiederkehr MR, Ma JZ, Kasiske BL. Chronic renal allograft rejection: immunologic and nonimmunologic risk factors. Kidney Int. 1996;49(2):518-524.
17. Sijpkens YW, Doxiadis II, Mallat MJ, et al. Early versus late acute rejection episodes in renal transplantation. Transplantation. 2003;75(2):204-208.
18. Shishido S, Asanuma H, Nakai H, et al. The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy. J Am Soc Nephrol. 2003;14(4):1046-1052.
19. Sis B, Jhangri GS, Bunnag S, Allanach K, Kaplan B, Halloran PF. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant. 2009;9(10):2312-2323.
20. Sis B, Halloran PF. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection. Curr Opin Organ Transplant. 2010;15(1):42-48.